{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:44:14Z","timestamp":1778561054301,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T00:00:00Z","timestamp":1690675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.coph.2023.102395","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T06:38:21Z","timestamp":1693031901000},"page":"102395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pharmacologic treatment of gastroparesis: What is (still) on the horizon?"],"prefix":"10.1016","volume":"72","author":[{"given":"D.","family":"Schweckendiek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0855-1152","authenticated-orcid":false,"given":"D.","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2023.102395_bib1","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3748\/wjg.v27.i24.3668","article-title":"Disorders of the brain-gut interaction and eating disorders","volume":"27","author":"Stanculete","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102395_sref2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.gastro.2021.10.028","article-title":"Gastroparesis","volume":"162","author":"Camilleri","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102395_sref3","doi-asserted-by":"crossref","DOI":"10.5009\/gnl210309","article-title":"A\u00a0new paradigm shift in gastroparesis management","author":"Mekaroonkamol","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.coph.2023.102395_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5009\/gnl19103","article-title":"Efficacy and safety of Ghrelin agonists in patients with diabetic gastroparesis: a systematic review and meta-analysis","volume":"14","author":"Hong","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.coph.2023.102395_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ueg2.12099","article-title":"European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: an EAGEN, ESNM, and ESPGHAN consensus, supported by EPC","volume":"9","author":"Keller","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.coph.2023.102395_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.2005.089508","article-title":"Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction?","volume":"56","author":"Karamanolis","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102395_bib8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.soard.2020.10.027","article-title":"Medical and surgical management of gastroparesis: a systematic review","volume":"17","author":"Fonseca Mora","year":"2021","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.coph.2023.102395_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2147\/CEG.S131650","article-title":"Diabetic gastroparesis: current challenges and future prospects","volume":"11","author":"Avalos","year":"2018","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.coph.2023.102395_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cts.12924","article-title":"YH12852, a potent and selective receptor agonist of 5-hydroxytryptamine, increased gastrointestinal motility in healthy volunteers and patients with functional constipation","volume":"14","author":"Lee","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.coph.2023.102395_sref14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MCG.0000000000001485","article-title":"Nausea and vomiting in 2021. A comprehensive update","volume":"55","author":"Heckroth","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.coph.2023.102395_bib15","article-title":"Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss - an observational study using the EFEMERIS database","author":"Vabre","year":"2021","journal-title":"Therapie"},{"key":"10.1016\/j.coph.2023.102395_bib16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.14309\/ajg.0000000000001805","article-title":"Cannabidiol for functional dyspepsia with normal gastric emptying: a randomized controlled trial","volume":"117","author":"Atieh","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102395_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.14309\/ajg.0000000000000181","article-title":"Cannabinoid use in patients with gastroparesis and related disorders: prevalence and benefit","volume":"114","author":"Jehangir","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102395_bib18","article-title":"Impact of cannabinoids on symptoms of refractory gastroparesis: a single-center experience","volume":"11","author":"Barbash","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.coph.2023.102395_sref19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11938-020-00323-w","article-title":"Cannabis in gastroenterology: watch your head! A review of use in inflammatory bowel disease, functional gut disorders, and gut-related adverse effects","volume":"18","author":"Nasser","year":"2020","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.coph.2023.102395_bib20","first-page":"5","article-title":"Placebo response and media attention in randomized clinical trials assessing cannabis-based therapies for pain: a systematic review and meta-analysis","volume":"1","author":"Gedin","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.coph.2023.102395_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/MCG.0000000000000257","article-title":"Small intestinal transit time is delayed in small intestinal bacterial overgrowth","volume":"49","author":"Roland","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.coph.2023.102395_bib23","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000280","article-title":"Buspirone for the management of functional dyspepsia with rapid gastric emptying","volume":"6","author":"Radetic","year":"2019","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.coph.2023.102395_bib24","article-title":"Prucalopride in diabetic and connective tissue disease-related gastroparesis: randomized placebo-controlled crossover pilot trial","volume":"33","author":"Andrews","year":"2021","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.coph.2023.102395_bib25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.14309\/ajg.0000000000000304","article-title":"Prucalopride in gastroparesis: a randomized placebo-controlled crossover study","volume":"114","author":"Carbone","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102395_bib26","article-title":"Role of prucalopride in treating functional constipation and gastroparesis: a systemic review","volume":"13","author":"Ali","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.coph.2023.102395_bib27","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/S0016-5085(10)60590-2","article-title":"A\u00a0novel gastrointestinal prokinetic, ATI-7505, increased spontaneous bowel movements (Sbms) in a phase II, randomized, placebo-controlled study of patients with chronic idiopathic constipation (CIC)","volume":"138","author":"Palme","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102395_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.gastro.2020.07.029","article-title":"Efficacy and safety of tradipitant in patients with diabetic and idiopathic gastroparesis in a randomized, placebo-controlled trial","volume":"160","author":"Carlin","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102395_bib32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/apt.16344","article-title":"Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study","volume":"53","author":"Kuo","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102395_bib33","article-title":"A\u00a0randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis","volume":"00","author":"Abell","year":"2023","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.coph.2023.102395_bib34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/apt.16304","article-title":"Randomised study: effects of the 5-HT4 receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis","volume":"53","author":"Chedid","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102395_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107961","article-title":"Effect of Oral CNSA-001 (sepiapterin, PTC923) on gastric accommodation in women with diabetic gastroparesis: a randomized, placebo-controlled, Phase 2 trial","volume":"35","author":"Abell","year":"2021","journal-title":"J\u00a0Diabet Complicat"},{"key":"10.1016\/j.coph.2023.102395_bib38","unstructured":"Personal communication via e-mail to the author on request from Glaxo Smith Kline, Medical Information Services, received September 2022."},{"key":"10.1016\/j.coph.2023.102395_bib39","article-title":"Discovery of DS-3801b, a non-macrolide GPR38 agonist with N-methylanilide structure","volume":"1","author":"Toda","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coph.2023.102395_bib40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.5056\/jnm15203","article-title":"Granisetron transdermal System for treatment of symptoms of gastroparesis: a prescription registry study","volume":"22","author":"Midani","year":"2016","journal-title":"J\u00a0of Neurogastroenterol and Motility"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:57:44Z","timestamp":1761461864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489223000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":30,"alternative-id":["S1471489223000504"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2023.102395","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic treatment of gastroparesis: What is (still) on the horizon?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2023.102395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102395"}}